TABLE 1

Echocardiographic Measurements Before and Serially After Intramyocardial Ad.EGFP or Ad.EGFP.NIS Injection

Ad.EGFPAd.EGFP.NIS
MeasurementBaselineDay 4Day 9BaselineDay 4Day 9
Heart rate (bpm)341 ± 40328 ± 63306 ± 42300 ± 29292 ± 33318 ± 52
LV dimension
 IVS thickness (mm)1.5 ± 0.41.6 ± 0.31.7 ± 0.31.6 ± 0.41.8 ± 0.61.8 ± 0.3
 PW thickness (mm)1.8 ± 0.11.8 ± 0.21.7 ± 0.21.7 ± 0.31.6 ± 0.21.8 ± 0.3
 Diastolic diameter (mm)6.8 ± 0.66.8 ± 0.97.5 ± 1.06.9 ± 0.86.8 ± 0.67.5 ± 0.9
 Systolic diameter (mm)3.1 ± 0.83.7 ± 1.04.2 ± 0.7*3.1 ± 0.93.3 ± 0.84.4 ± 0.8*
 IVS/LVPW ratio0.9 ± 0.10.9 ± 0.11.0 ± 0.21.0 ± 0.21.1 ± 0.31.0 ± 0.2
 Diastolic volume (mL)0.7 ± 0.20.7 ± 0.31.0 ± 0.30.7 ± 0.20.7 ± 0.21.0 ± 0.3
 Systolic volume (mL)0.1 ± 0.00.2 ± 0.10.2 ± 0.1*0.1 ± 0.10.1 ± 0.10.2 ± 0.1
 LV mass (g)0.7 ± 0.10.8 ± 0.20.9 ± 0.20.7 ± 0.10.8 ± 0.21.0 ± 0.2
LV functional parameter
 LV FS (%)54.7 ± 10.046.7 ± 7.643.6 ± 4.954.3 ± 9.148.6 ± 5.042.4 ± 4.7*
 LV EF (%)88.2 ± 6.482.3 ± 7.779.6 ± 5.0*88.0 ± 5.486.5 ± 5.778.7 ± 4.6*
  • * P < 0.005 compared with baseline measurements.

  • P < 0.05 compared with baseline measurements.

  • P < 0.01 compared with baseline measurements.

  • IVS = interventricular septum; PW = posterior wall; LVPW = LV posterior wall; LVFS = LV fractional shortening.

  • Data are mean ± SD.